Fortress Biotech, Inc.

FBIO
Sell Open
Signal type
Sell
Status
Open
Open Price
$2.96
Stop Loss
$3.40
Performance
18.10%
Days Open
26

Signal Setup

Signal Type Sell
Status Open
Open Date Mar 20, 2026
Open Price $2.96
Stop Loss $3.40
Timespan Day

Company Profile

Name Fortress Biotech, Inc.
Ticker FBIO
Market Cap $53.82M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $2.42
List Date Nov 17, 2011
Description

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.